Author Archive: Paulina Ibarra

Paulina was the director of web and new media communications with the Biotechnology Industry Organization from October 2010 - June 2013.

Latest Posts

Biotech Business: Wait Our Model Isn’t Dead

Life sciences company and investment executives debated the current and future viability of the industry model for startup companies, given the tumultuous economic waters it traversed during the so-called Great Recession of 2008-2009. The aptly-named panel (“Wait, Our Model Isn’t Dead! We Just Need to Evolve”) appraised those lean times for biotech in a justifiable effort to explain the dramatic decline of startup generation and flow of available investment funding since the peak of the Read More >

Business of Biotech  |  1 Comment  |  Email This Post
Tags:

Biotechnology – Creating a positive political and social environment

Tony Blair at 2011 BIO International Convention

“I think it’s important that government stands up for proper science,” Former British Prime Minister Tony Blair said during the Tuesday keynote luncheon at the 2001 BIO International Convention. “You know I had a lot of battles over this when I was prime minister – with various groups.” This was a familiar story to many of the attendees who regularly face a number of social and political hurdles in bringing their innovative products to market: Read More >

Events  |  1 Comment  |  Email This Post
Tags: , , ,

Author of Building Biotechnology Onsite at the 2011 BIO International Convention

Yali Friedman,  author of Building Biotechnology as well as other books is signing books at the BIO bookstore from 3pm to 4:30pm at the 2011 BIO International Convention.

Business of Biotech  |  1 Comment  |  Email This Post
Tags: , ,

Thoughts on the Partnering for Global Health Forum

Angie Drakulich posts on PharmTech Talk her thoughts on the Partnering for Global Health Forum, being held at the 2011 BIO International Convention.  The Forum presented a unique panel of government leaders from emerging markets, discussing what it takes to do business in their countries.

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , ,

Biotech in the age of new media

In the age of new media, sharing information about a prescription drug is even more perilous than ever. Despite promises of guidelines in 2009, the FDA still has yet to issue clear guidance to pharmaceutical companies about how to remain in compliance with regulations while using the appealing and affordable medium of new media to disseminate information. In their panel, “Talking About Your Product in the New Age: Social Media and the Internet,” moderator John Read More >

Corporate  |  Leave a comment  |  Email This Post